DETERMINANTS OF STOCK PRICE IN PHARMACEUTICALS SECTOR: PRE COVID-POST COVID ANALYSIS

Abstract

Purpose Stock price of a company has an array of considerations for the stakeholders which nevertheless shape market reputation. With due regards to which the following study has been conducted with the aim to proclaim that impact of Book Value Per share (BVPS), Dividend Per share (DVS), Inflation, Gross-Domestic Product (GDP), Size of the firm, Organizational Performance, along with the tenure of pre-and post-COVID scenario on the stock price ofthe chosen companies ofpharmaceutical industiy in Pakistan. Methodology & Design In order to fulfil the technical ideology ofthe resulting study, a quantitative research design has been deployed. Where with secondary collection from the annual reports, books, and financial reports from the year 2010-2020 data has been retrieved for data analysis. Findings The following study has determined the findings that DVS, Size of the firm, COVID’19, BVPS, and organizational performance have found to have a non-negotiable impact upon the selected pharmaceutical companies operating in Pakistan. Limitations Due to time, and resource limitations the resulting study could not focus on a broad range of industries which then would be beneficial for the upcoming scope for the future researches of similar nature. Recommendations For future researches of the same nature, the resulting study has recommended to propose avenues which flourish the leading entrepreneurs and young minds with the correct knowledge about stock market ofPakistan. Moreover, for industiy owners it is recommended to have the participation sort out where with coming externalities including inflation, or GDP the stock investment decisions are revised likewise for a long-term and sustainable result.